INGR Ingredion Incorporated
Price Chart
Executive Summary
Ingredion acquired Benicaros, a patented prebiotic carrot fiber with clinical immune-health data, in an asset deal including all IP and manufacturing know-how. The acquisition expands Ingredion's functional ingredients portfolio with a differentiated, upcycled product that addresses formulation challenges of traditional prebiotics. Deal value was not disclosed, limiting immediate financial impact assessment.
Actionable Insight
Monitor for future disclosure of deal terms in Ingredion's 10-Q or 8-K filings. The acquisition is a small bolt-on to expand functional ingredients but lacks financial details to move the stock near-term.
Key Facts
- Acquired Benicaros, a patented prebiotic fiber from upcycled carrot pomace with clinical immune-health benefits
- Asset deal includes full ownership of IP, trademarks, clinical trials, and manufacturing know-how
- Benicaros is water-soluble, low-dosage, plant-based, clean-label, kosher, halal, gluten-free, and upcycled
- Ingredion had 2025 annual net sales of approximately $7.2 billion
- Deal value was not disclosed in the press release
Financial Impact
Deal value undisclosed; likely immaterial relative to Ingredion's $7.2B annual sales and $6.4B market cap
Risk Factors
- Undisclosed deal value could be larger than implied, but likely small relative to Ingredion's scale
- Integration risk and commercial adoption of a novel prebiotic ingredient may take time
- No revenue or earnings guidance provided for the acquired asset
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3304942 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
4d ago
|
Press Release
| — | awaiting T+5 | — | — |
|
May 28, 2026
9d ago
|
Press Release
| $103.21 $100.90 | ▼ −2.24% | ▼ −2.19% | $99.98 (−3.13%) |
|
May 20, 2026
17d ago
|
Press Release
| — | awaiting T+5 | — | — |
|
May 14, 2026
23d ago
|
8-K
| $102.25 $102.15 | ▼ −0.10% | ▲ +0.62% | $99.98 (−2.22%) |
|
May 5, 2026
4w ago
|
Press Release
| $107.13 $106.20 | ▲ +0.87% | ▲ +2.85% | $99.98 (+6.67%) |
|
Apr 14, 2026
7w ago
|
Press Release
| $112.70 $112.62 | ▼ −0.07% | ▼ −1.71% | $99.98 (−11.29%) |
|
Apr 8, 2026
8w ago
|
DEFA14A
| $113.56 $112.70 | ▼ −0.76% | ▼ −4.27% | $99.98 (−11.96%) |
|
Mar 18, 2026
11w ago
|
Press Release
| $109.44 $111.01 | ▲ +1.43% | ▲ +3.64% | $99.98 (−8.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access